Corcept Therapeutics (CORT) Debt Ratio (2012 - 2023)

Corcept Therapeutics (CORT) reported Debt Ratio of 0.02 for Q4 2023, down 6.13% on a YoY basis from 0.02 in Q4 2022, and down 4.42% sequentially from 0.02 in Q3 2023.

Corcept Therapeutics (CORT) Debt Ratio (2012 - 2023) Analysis & Trends

Corcept Therapeutics (CORT) has 8 years of Debt Ratio data on file, last reported at 0.02 in Q4 2023.

  • For the quarter ending Q4 2023, Debt Ratio fell 6.13% year-over-year to 0.02; the trailing twelve-month figure through Dec 2023 stood at 0.02 (down 6.13% YoY), and the FY2023 full-year result was 0.02, down 6.13% from the prior year.
  • Debt Ratio eased to 0.02 in Q4 2023, from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.03 in Q2 2023 to a low of 0.02 in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 1.41
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.11
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.05
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Corcept Therapeutics 9.99 Bn 9.65 Bn 162.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.03
Mar 31, 2023 0.02
Dec 31, 2022 0.02
Jun 30, 2017 0.05
Mar 31, 2017 0.13
Dec 31, 2016 0.21
Sep 30, 2016 0.30
Jun 30, 2016 0.39
Mar 31, 2016 0.47
Dec 31, 2015 0.53
Sep 30, 2015 0.61
Jun 30, 2015 0.65
Mar 31, 2015 0.68
Dec 31, 2014 0.98
Sep 30, 2014 0.93
Jun 30, 2014 0.79
Mar 31, 2014 0.66
Dec 31, 2013 0.56